Literature DB >> 3356784

Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans.

R R Rosato1, F F Macasaet, P B Jahrling.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) were developed for detection of immunoglobulin G (IgG) and IgM antibodies to Venezuelan equine encephalomyelitis (VEE) virus in vaccinated and naturally infected humans. A total of 441 sera found negative for VEE antibodies by plaque reduction neutralization were examined by IgG ELISA and gave a 1.0% false-positive rate; no false-positives were found in the IgM ELISA. Sera with neutralizing antibody to western or eastern equine encephalomyelitis virus did not react with VEE antigen in the IgG ELISA. Sensitivity of the IgG ELISA was determined by testing 100 coded pre- and postvaccination human sera. Sixty-two were positive by ELISA; 58 of these 62 were also positive by neutralization tests, and 38 were negative by both tests. No neutralization-positive, ELISA-negative sera were found. Comparison of titers obtained by ELISA and neutralization tests indicated that 88% varied randomly by a fourfold dilution factor or less, while 61% were identical or varied only twofold. In sera obtained sequentially from 10 vaccinees and 5 naturally infected patients, both IgG and IgM antibodies appeared between 2 and 3 weeks after vaccination or onset of symptoms. The IgG and IgM antibody ELISAs described are rapid, specific, and sensitive indicators of VEE antibody status in vaccinated and naturally infected individuals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356784      PMCID: PMC266305          DOI: 10.1128/jcm.26.3.421-425.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells.

Authors:  P B Jahrling; L Gorelkin
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

2.  Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.

Authors:  D S Burke; H H Ramsburg; R Edelman
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

3.  Clinical aspects of human Venezuelan equine encephalitis in Texas.

Authors:  G S Bowen; T R Fashinell; P B Dean; M B Gregg
Journal:  Bull Pan Am Health Organ       Date:  1976

4.  Rapid diagnosis of tick-borne encephalitis by means of enzyme linked immunosorbent assay.

Authors:  H Hofmann; W Frisch-Niggemeyer; F Heinz
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

5.  Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus.

Authors:  T E Walton; O Alvarez; R M Buckwalter; K M Johnson
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

6.  The natural occurrence of Venezuelan equine encephalitis in the United States.

Authors:  N J Ehrenkranz; M C Sinclair; E Buff; D O Lyman
Journal:  N Engl J Med       Date:  1970-02-05       Impact factor: 91.245

7.  An outbreak of Venezuelan encephalitis in man in the Panamá Canal Zone.

Authors:  P T Franck; K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1970-09       Impact factor: 2.345

8.  Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance.

Authors:  N A Young; K M Johnson
Journal:  Am J Epidemiol       Date:  1969-03       Impact factor: 4.897

9.  Ten clinical cases of human infection with venezuelan equine encephalomyelitis virus, subtype I-D.

Authors:  W H Dietz; P H Peralta; K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1979-03       Impact factor: 2.345

10.  Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay.

Authors:  R H Yolken; R G Wyatt; H W Kim; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  4 in total

1.  Antibody and Viral Nucleic Acid Testing of Serum and Cerebrospinal Fluid for Diagnosis of Eastern Equine Encephalitis.

Authors:  James A Sherwood; David C Brittain; John J Howard; JoAnne Oliver
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

2.  Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83.

Authors:  B Negrette; E Bonilla; N Valero; H Pons; J Garcia Tamayo; L Chacín-Bonilla; S Medina-Leendertz; F Añez
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

3.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

Review 4.  Medically important arboviruses of the United States and Canada.

Authors:  C H Calisher
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.